Pfizer made 6 mln courses of COVID pill, hitting Q1 target
April 4 (Reuters) - Pfizer Inc said on Monday it made 6 million courses of its antiviral COVID-19 pill Paxlovid in the first quarter, hitting a target set...
April 4 (Reuters) - Pfizer Inc said on Monday it made 6 million courses of its antiviral COVID-19 pill Paxlovid in the first quarter, hitting a target set...